The Role of TLR4 on Lipid-induced Insulin Resistance

NCT02321111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Insulin Sensitivity

Interventions

DRUG: Eritoran
DRUG: D5W (5% Dextrose in water)

Sponsor

The University of Texas Health Science Center at San Antonio